Invesco’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Invesco’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,894,463	Closed	-$52.2M	–	4078
2021 Q2	$52.2M	Sell	1,894,463 -27,954	-1%	-$549K	0.01%	1064
2021 Q1	$31.7M	Sell	1,922,417 -5,918	-0.3%	-$135K	0.01%	1278
2020 Q4	$35.5M	Buy	+1,928,335	New	+$34.5M	0.01%	1154
2020 Q2	–	Sell	-51,140	Closed	-$509K	–	3715
2020 Q1	$509K	Buy	+51,140	New	+$419K	﹤0.01%	3045
2019 Q3	–	Sell	-79,539	Closed	-$1M	–	3739
2019 Q2	$1M	Buy	+79,539	New	+$839K	﹤0.01%	3074

Invesco's TBIO Position: Q3 2021 in Review

Invesco sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,894,463 shares — an estimated $52.2M sold.

Invesco first reported a position in TBIO in Q2 2019 and held it in 5 quarters. The position peaked at $52.2M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Invesco reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Invesco sold 1,894,463 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $52.2M.
Invesco first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
Invesco's Translate Bio, Inc. Common Stock position peaked at $52.2M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Invesco's 13F filing for Q3 2021, filed 15 Nov 2021.